Navigating Cell Therapy Categorization in Regulatory Frameworks

Published on Cell & Gene

Cell therapy products often sit in regulatory gray zones due to their complex nature. This article explores how subtle differences in manipulation, sourcing, and intended use can affect categorization, and why understanding these distinctions is critical for regulatory strategy.

Read the full article on Cell & Gene:

👉 Beyond Definitions: The Intricacies of Cell Therapy Categorization

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.